— Know what they know.
Not Investment Advice
Also trades as: KMDA.TA (TLV) · $vol 1M

KMDA NASDAQ

Kamada Ltd.
1W: -4.7% 1M: -1.1% 3M: +10.9% YTD: +18.2% 1Y: +21.5% 3Y: +67.9% 5Y: +59.8%
$8.31
+0.11 (+1.34%)
 
Weekly Expected Move ±5.8%
$7 $8 $8 $9 $9
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 47 · $479.4M mcap · 31M float · 0.295% daily turnover · Short 46% of daily vol

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$195M +21.4% ▲
5Y CAGR: +8.0%
Gross Profit
$78M +11.9% ▲
5Y CAGR: +10.5%
Operating Income
$28M +41.6% ▲
5Y CAGR: +8.1%
Net Income
$22M +51.2% ▲
5Y CAGR: +5.0%
EPS (Diluted)
$0.37 +48.0% ▲
5Y CAGR: -2.0%
EBITDA
$45M +60.2% ▲
5Y CAGR: +11.9%

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
Revenue$104M$129M$143M$161M$195M
YoY Growth-22.2%+24.8%+10.2%+12.9%+21.4%
Cost of Revenue$73M$83M$87M$91M$117M
Gross Profit$30M$47M$55M$70M$78M
Gross Margin29.3%36.1%38.9%43.5%40.1%
R&D Expenses$11M$13M$14M$15M$13M
SG&A Expenses$18M$25M$27M$31M$37M
Operating Expenses$31M$42M$45M$50M$50M
Operating Income-$696K$5M$10M$20M$28M
Operating Margin-0.7%3.5%7.1%12.5%14.5%
Interest Expense$283K$914K$1M$660K$935K
Income Before Tax-$2M-$2M$8M$13M$25M
Tax Expense$345K$62K$145K-$1M$4M
Net Income-$2M-$2M$8M$14M$22M
Net Margin-2.2%-1.8%5.8%9.0%11.2%
EPS (Diluted)$-0.05$-0.05$0.15$0.25$0.37
EBITDA$4M$11M$22M$28M$45M
Shares Outstanding45M45M54M58M58M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms